PharmAbs focuses on the development of novel antibody/nanobody discovery and delivery technologies and innovative antibody-based therapeutics and diagnostics. PharmAbs’ expertise and technologies are used to translate basic scientific innovations emerging at universities into diagnostic/therapeutic solutions for personalized medicine that can be implemented in the clinic and/or commercialized by third parties.